Health Care Resolved: Give us the Congressional Plan

BettyJean Kling

Our President and the house and Senate convened in a special meeting this morning all telling us their employers that they have our best interests at heart and what they and we all have in common is this one thing; all Americans deserve and want and need affordable health care. I agree – how about you?

Here they sit fighting over three different plans all written exclusively by democrats and fought over  bitterly by Blue Dog Democrats and Republicans alike while Americans have increasingly done without while paying these fools to fight over the same while the answer is as plain as the nose on their faces.

According to Steny Hoyer, 5Th. Congressional District Maryland, he has a plan that is affordable and does not restrict pre-existing conditions. While reiterating his deep concern for Americans this morning he announced that he wants all Americans to have as good as he has.  I agree – how about you?

The President has said over and over that he has great heath care for he a his family and always will- need I remind you who pays for that health care? Mr. Obama  along with Nancy, Harry and Steny tell us they want us to all have Health Care as good as theirs.  I agree – how about you? As if rubbing salt in our wounds – We The People have been reminding all 535 of them and POTUS and Company of this very point all along.

Why don’t they understand and why can’t we all have what they have? It costs about $1200.00 a year for the Representative and his family for life it’s a Cadillac plan, has no restrictions, and it is not NOT Government Run! 

What a novel idea.

I think he single handedly pointed right to the solution!

I asked my Congressman last August and many Americans asked their Congresspersons as well but none are suggesting the perfect answer. So Mr. Obama, the dilemma is solved. Stop the summit and give us what you and the Congress has.

Demand the Insurance companies currently covering the hundreds of thousands of government employees to also cover the 300 million Employers with the same coverage. How’s that for a large pool?

Eureka! – Health Care coverage and cost s solved!

Healthcare industry lobbies for Coakley, but I thought they were the Republican’s Astroturf?

BettyJean Kling

If Health Care was meant to benefit the people instead of the Insurance Companies and Big Pharma then the people instead of the Insurance Companies and Big Pharma would be fighting like hell to keep the 60th seat in Democratic hands right?

Likewise, if Big Pharma and Insurance companies were really the Astroturf behind the August Town Halls trying to kill health care reform, wouldn’t they be pumping money into the Brown Campaign now? Of course they would.

But what would it mean if they are pumping money into the Coakley campaign in order to keep the 60th seat in Democratic hands? Fool you once shame on them – fool you twice – then you are just a damned fool! Perhaps this will awaken you? If Coakley wins then you had better join the tea parties and march your buts down to DC and help us stop this – as you can see- its just another Obama lie! let’s see what did he call them when he said they were really working for the other side? Oh that’s right – Fat Cats! Well those Fat Cats and Lobbyists are now  desperately trying to defeat Scott Brown. Hmmmmm


This outlines the incredibly nasty deal Obama made with the big pharmaceutical companies.  It stinks to high heaven and hurts consumers.  Chicago politics at its worst.  Although it’s from Huffington Post, it is accurate (and others have confirmed it).

White House Pharma Memo 

Internal Memo Confirms Big Giveaways In White House Deal With Big Pharma

We’ve been following the special election in Massachusetts, where the GOP hopes to pull a surprise upset in the race to fill Ted Kennedy’s seat.

If they do pull it off, healthcare reform is instantly in trouble, as the Democrats drop below 60. But money is coming to the rescue of Democrat Martha Coakley — healthcare industry lobbyist money, specifically.Tim Carney identifies several of her top fundraisers. Take a look at who they represent:…

  • Thomas Boggs, Patton Boggs: Bristol-Myers Squibb
  • Chuck Brain, Capitol Hill Strategies: Amgen, BIO, Merck, PhRMA
  • Susan Brophy, Glover Park Group: Blue Cross, Pfizer
  • Steven Champlin, Licy Do Canto, Raben Group: Amgen
  • Gerald Cassidy, Cassidy & Associates: U. Mass Memorial Health Care
  • David Castagnetti, Mehlman, Vogel, Castagnetti: Abbot Labs, AHIP, Astra-Zenaca, General Electric, Humana, Merck, PhRMA.
  • Steven Elmendorf, Elmendorf Strategies: Medicines Company, PhRMA, United Health
  • Shannon Finley, Capitol Counsel: Amgen, Astra-Zeneca, Blue Cross, GE, PhRMA, Sanofi-Aventis.
  • Heather Podesta, Heather Podesta & Partners: Cigna, Eli Lilly, HealthSouth
  • Tony Podesta, Podesta Group: Amgen, GE, Merck, Novartis.
  • Robert Raben, Raben Group: Amgen, GE.
Of course, this is how politics works. Lobbyists for various corporations and causes get involved wherever they can for candidates of both parties.
 But when you see all these big pharma (and insurance!) representatives coming with cash for a crucial vote, you know which side they’re on. And they are definitely not on the side the Democrats tried to tell you the were on are they? Why is that? Could it be that this health care bill suits them better than it suits We The People? It certainly can’t suit all of us at once can it? Obama and Reid and Pelosi told us these characters were paying the Republicans to stop the health care bill and here they are trying to make sure it passes! Hmmmmmm! IMAGINE THAT!

Health Care Reform Still Not Addressing Cost

Health care reform is yet to substantively deal with ‘gorilla in the room’ – Cost. This is one of the fundamental reason why health care reform is needed. Yet no plan truly deals with this problem adequately. With the federal deficit shooting upwards and the country in the middle of a recession this only makes the need to deal with cost that much more pointed, but it does not seem to be a legislative priority.

Mort Kondracke of Roll Call explains in his article Will Reform Cut Health Care Costs? Don’t Bet on It that the health care reform plans have no enforceable cost reducing measures. Cost cutting measures that are attempted rely on insurance companies, drug companies, and other health groups to keep their word and cut costs. This is at best a gamble, and not a very good one at that.

There’s reason to fear that, even with reform, the nation’s total outlays for health care – currently 17 percent of gross domestic product – will continue to soar, and so will federal health spending and insurance premiums.

The Obama White House promised reform would “bend the curve” of health spending – now growing 3 percent a year faster than the economy – but bills pending in Congress contain no guaranteed cost-containment measures such as a global budget, or national lid, on health spending.

According to the Congressional Budget Office, total U.S. health spending is scheduled to rise to 20 percent of the GDP by 2018, 25 percent by 2025 and 38 percent by 2050.

In May, health care stakeholder groups, including hospitals, insurance companies, doctors, drug companies and device makers, promised President Barack Obama they’d institute measures shaving 1.5 percent per year from the current 7 percent growth rate of health spending, saving $2 trillion over 10 years.

But as the journal Health Affairs observed in an issue brief in August, “these agreements are not enforceable” and, indeed, House “reform” legislation would free doctors from any reductions in Medicare reimbursements.

It’s no wonder the American Medical Association supports the House bill, H.R. 3200. The Senate Finance Committee bill gives doctors just a one-year break from scheduled fee reductions, but past patterns are that Congress annually saves doctors from any cut.

Another group promising cuts – and now supporting Obamacare – is the Pharmaceutical Research and Manufacturers of America.

Its contribution to controlling health care costs? Just $80 billion over 10 years – out of total U.S. pharmaceutical outlays of $3.3 trillion.

And, as Fortune magazine pointed out, part of PhRMA’s cuts are designed to get more Medicare recipients to use brand-name drugs when generics actually would be cheaper.

According to Health Affairs Editor-in-Chief Susan Dentzer, “bending the curve” of health cost growth depends upon “a lot of floating magic asterisks” in the Senate legislation, including the transformation of several pilot projects into actual policies that alter health spending patterns.

No Good News On Health Care Costs